Economic evaluation of biosimilars for reimbursement purposes – what, when, how?

Background: Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness of and explore methodological issues for the economic evaluation of biosimila...

Descripción completa

Detalles Bibliográficos
Autores principales: Moorkens, Evelien, Broux, Hannah, Huys, Isabelle, Vulto, Arnold G., Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144192/
https://www.ncbi.nlm.nih.gov/pubmed/32284827
http://dx.doi.org/10.1080/20016689.2020.1739509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144192/
https://www.ncbi.nlm.nih.gov/pubmed/32284827
http://dx.doi.org/10.1080/20016689.2020.1739509

Ejemplares similares